CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Nivien Therapeutics
Nivien Therapeutics logo

Nivien Therapeutics

Nivien Therapeutics: Pioneering developer of LATS1/2 kinase inhibitors.

San Francisco, CA, US🇺🇸
Founded
2016
Overview
Compare
Fundraising
Employees

Nivien Therapeutics is a pioneering developer of LATS1/2 kinase inhibitors, focusing on small molecule therapeutics. The company's mission is to advance innovative treatments targeting critical pathways in disease processes. Their market focus includes oncology and other areas where LATS1/2 kinases play a significant role.

Nivien Therapeutics has achieved notable progress in the development of its proprietary inhibitors, positioning itself as a leader in this niche. Their work has the potential to significantly impact treatment paradigms in oncology, offering new hope for patients with limited options.

Nivien Therapeutics - Similar Companies

NiKang Therapeutics logo

NiKang Therapeutics

nikangtx.com

Vibliome Therapeutics logo

Vibliome Therapeutics

vibliome.com

Nirogy Therapeutics logo

Nirogy Therapeutics

Civetta Therapeutics logo

Civetta Therapeutics

Nimbus Therapeutics logo

Nimbus Therapeutics

nimbustx.com

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Novita Therapeutics logo

Novita Therapeutics

Nerio Therapeutics logo

Nerio Therapeutics

Initial Therapeutics logo

Initial Therapeutics

initialtx.com

NantBio logo

NantBio

Vivace Therapeutics logo

Vivace Therapeutics

Oviva Therapeutics logo

Oviva Therapeutics

ovivatx.com

Anivive logo

Anivive

anivive.com

KeifeRx logo

KeifeRx

keiferx.com

NKT Therapeutics logo

NKT Therapeutics

Nivien Therapeutics - Quick Facts

Who are Nivien Therapeutics' competitors?

Companies similar to Nivien Therapeutics include NiKang Therapeutics, Vibliome Therapeutics, Nirogy Therapeutics and Civetta Therapeutics.

When was Nivien Therapeutics founded?

Nivien Therapeutics was founded in 2016.

Where is Nivien Therapeutics' headquarters located?

Nivien Therapeutics' headquarters is located in San Francisco, CA, US.

When was Nivien Therapeutics' last funding round?

Nivien Therapeutics' most recent funding round was for $600k (USD) in December 2017.

How much disclosed funding has Nivien Therapeutics raised?

As of Dec 1, 2017, Nivien Therapeutics has disclosed funding of $600k (USD). Undisclosed round amounts are excluded.

How many employees does Nivien Therapeutics have?

Nivien Therapeutics has 7 employees as of Feb 4, 2024.

Nivien Therapeutics - Classification

Ownership
  • Private
  • Venture-backed
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Small Molecules
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified